Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 4Withdrawn 1Unknown 1Terminated 1Not yet recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1Classical hematology 1

Conditions

Neoplasms, Plasma Cell 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Anemia 1

Interventions

Cisplatin 514Radiotherapy 376Cyclophosphamide 364Carboplatin 356Capecitabine 342Oxaliplatin 334Paclitaxel 331Gemcitabine 320Docetaxel 315Fluorouracil 290Drug Therapy 273Bevacizumab 247apatinib 246camrelizumab 218Etoposide 200Irinotecan 183Doxorubicin 181Leucovorin 163Dexamethasone 160pembrolizumab 154sintilimab 143Neoadjuvant Therapy 143anlotinib 140Blood Specimen Collection 139Pemetrexed 138Cytarabine 138toripalimab 131Surgical Procedures, Operative 131Radiosurgery 127S 1 (combination) 125

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Ferric Oxide, Saccharated × Clear all
NCT00482716 2014-01-10

Epoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in Patients With Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
80 enrolled
Classical hematologyLymphoidOther hematologic neoplasmPlasma cell

Anemia, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡